Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSL425 (H1N1 Vaccine) in Healthy Children
NCT00940108Phase 2Completed
- Sponsor
- CSL Seqirus
- Start
- Aug 2009
- Primary completion
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant influenza ha vaccine (h5n1) in influenza A H1N1 infection (H1N1), sponsored by CSL Seqirus. Started Aug 2009; status: completed.
02
Drugs
recombinant influenza ha vaccine (h5n1)
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00940108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940108.